Log in to your Inderes Free account to see all free content on this page.
CellaVision
161.80 SEK
+1.38 %
1,475 following
CEVI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for CellaVision
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
Dividend yield
Median 2019-2025
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 319.50 | 307.00 | 325.20 | 229.00 | 212.00 | 217.50 | 157.20 |
| Shares | 23.9 | 23.9 | 23.9 | 23.9 | 23.9 | 23.9 | 23.9 |
| Market cap | 7,620.7 | 7,322.6 | 7,756.7 | 5,462.0 | 5,056.5 | 5,187.7 | 3,749.5 |
| Enterprise value | 7,678.5 | 7,353.1 | 7,763.0 | 5,456.5 | 4,999.6 | 5,065.1 | - |
| EV/S | 16.6 | 15.6 | 13.7 | 8.5 | 7.4 | 7.0 | - |
| EV/EBITDA | 52.3 | 51.5 | 39.6 | 27.6 | 24.2 | 23.1 | - |
| EV/EBIT | 60.7 | 66.7 | 47.7 | 34.5 | 29.9 | 28.5 | - |
| P/E | 76.8 | 81.8 | 61.9 | 46.2 | 38.8 | 36.9 | 24.5 |
| P/B | 21.88 | 17.04 | 14.28 | 8.51 | 7.06 | 6.36 | 4.22 |
| P/S | 16.5 | 15.5 | 13.7 | 8.5 | 7.5 | 7.2 | 4.9 |
| Dividend yield | 0.0 % | 0.2 % | 0.6 % | 0.9 % | 1.1 % | 1.2 % | 1.8 % |
| Equity ratio | 54.3 % | 64.3 % | 65.8 % | 72.0 % | 77.1 % | 80.6 % | 81.1 % |
| Gearing ratio | 45.9 % | 30.9 % | 25.2 % | 16.0 % | 9.0 % | 3.3 % | 2.9 % |
Login required
This content is only available for logged in users